SoVote

Decentralized Democracy

House Hansard - 320

44th Parl. 1st Sess.
May 29, 2024 02:00PM
Context: House Hansard - 320 - May/29/24
Right Hon. Justin Trudeau (Prime Minister, Lib.)
  • May/29/24 2:25:05 p.m.
  • Watch
Mr. Speaker, the Conservative Party invoked inflation to oppose our dental care plan for seniors and our investments to pay for dental care for the most vulnerable, who may not have been to a dentist in years, or even decades. Is that inflation? No, it is help for Canadians who are struggling, who are having a hard time paying for groceries and who are worried about the cost of living. It is help that we are sending and that the Conservative Party is blocking at all costs. That is not being there for Canadians.
94 words
  • Hear!
  • Rabble!
  • star_border
Context: House Hansard - 320 - May/29/24
Hon. Pierre Poilievre (Leader of the Opposition, CPC)
  • May/29/24 2:42:31 p.m.
  • Watch
Mr. Speaker, housing costs have doubled since he became Prime Minister. They were half when I was housing minister. Housing costs have gone up 40% faster than wages, a bigger gap than in any other G7 country. Why is that? It is because the Prime Minister is building bureaucracy and not homes. Why will he not accept my common-sense plan to require municipalities to permit 15% more building, sell off 6,000 federal buildings to build homes and cut taxes so builders can build?
85 words
  • Hear!
  • Rabble!
  • star_border
Context: House Hansard - 320 - May/29/24
Mr. Mike Morrice
  • May/29/24 11:08:41 p.m.
  • Watch
Madam Chair, I am encouraged to hear that on both fronts. I appreciate that. I would like to tell the minister about another constituent of mine, Noor Ayesha. Noor is battling an incurable rare cancer. For it, she requires an oral drug. The name is Pemazyre. It has been approved by Health Canada but is not recommended by the Canadian drug agency for public coverage. Noor's oncologist recommends that she take this drug to help her live longer, but it costs $800 U.S. per tablet and has to be taken daily. It is a cost of over $15,000 U.S. per month. Here is what Dr. Jennifer Knox, a medical oncologist at the Princess Margaret Cancer Centre and professor of medicine at the University of Toronto, had to say about Pemazyre: “this drug represents real progress, a key scientific and clinical advancement.” Noor's family has had to turn to starting a GoFundMe to help her fight cancer and live longer because the Canadian drug agency has not recommended Pemazyre for coverage. What steps is the government taking to address this gap between Health Canada's approval of rare cancer drugs and the CDA's recommendations for public coverage in order to ensure that patients like Noor can access the treatment they need without prohibitive costs?
221 words
  • Hear!
  • Rabble!
  • star_border
Context: House Hansard - 320 - May/29/24
Hon. Mark Holland (Minister of Health, Lib.)
  • May/29/24 11:45:37 p.m.
  • Watch
Madam Chair, it is precisely because diabetes is a precursor illness, that diabetes, when improperly managed, leads to heart disease, stroke, blindness, kidney failure and amputation. It is unfortunately right now costing, as of the latest estimate, from 2018, $28 billion to our health system. It is estimated in a 10-year period to increase to $37 billion. We have to turn the tide. We need to make sure that people are effectively managing their diabetes so that we do not get those bad outcomes, so that it costs the system less. Fundamentally, it really is an issue of prevention.
100 words
  • Hear!
  • Rabble!
  • star_border